Genetic variability among yellow fever virus 17D substrains

Vaccine

Volumn 16, Issue 9-10, 1998, Pages 1024-1028

  Galler, Ricardo ^a,b   Post, Paulo R ^a   Santos, Claudia N D ^a   Ferreira, Idevaldo I ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Instituto de Technologia em Imunobiologicos   (Brazil)

Author keywords

Flaviviruses; Genetic variation; Yellow fever virus

Indexed keywords

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; GENETIC VARIABILITY; MUTATION RATE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; VACCINE PRODUCTION; YELLOW FEVER FLAVIVIRUS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA, COMPLEMENTARY; DNA, VIRAL; GENOME, VIRAL; HUMANS; PHENOTYPE; SPECIES SPECIFICITY; VACCINES, ATTENUATED; VARIATION (GENETICS); VIRAL PROTEINS; VIRAL VACCINES; VIRULENCE; YELLOW FEVER VIRUS;

EID: 0032078755     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00278-8     Document Type: Article

References (14)

1. 1 Chambers, T.J., Hahn, C.S., Galler, R. and Rice, C.M. Flavivirus genome organization, expression and evolution. Annual Reviews in Microbiology 1990, 44, 649.
2. 2 Stokes, A., Bauer, J.H. and Hudson, N.P. The transmission of yellow fever to Macacus rhesus, preliminary note. American Journal of Tropical Medicine and Hygiene 1928, 8, 103.
3. 3 Theiler, M. and Smith, H.H. The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus. Journal of Experimental Medicine 1937, 65, 787.
4. 4 Hahn, C.S., Dalrymple, J.M., Strauss, J.H. and Rice, C.M. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proceedings of the National Academy of Science USA 1987, 84, 2029.
5. 5 Fox, J.P. and Penna, H.A. Behavior of 17D yellow fever virus in rhesus monkeys. American Journal of Hygiene 1943, 38, 52.
6. 6 Monath, T.P., Brinker, K.R., Chandler, F.W., Kemp, G.E. and Cropp, C.B. Pathophysiologic correlations in a rhesus monkey model of yellow fever. American Journal of Tropical Medicine and Hygiene 1981, 30, 431.
7. 7 Rice, C.M., Grakoui, A., Galler, R. and Chambers, T.J. Transcription of infectious yellow fever RNA from full-length templates produced by in vitro ligation. The New Biologist 1989, 1, 285.
8. 8 Marchevsky, R.S., Mariano, J. and Ferreira, V.S. et al. Phenotypic analysis of yellow fever virus derived from complementary DNA. American Journal of Tropical Medicine and Hygiene 1995, 52, 75.
9. 9 Monath, T.P., Kinney, R., Schlesinger, J.J., Brandriss, M.W. and Bres, P. Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analysis of vaccines produced world-wide. Journal of General Virology 1983, 64, 627.
10. 10 Duarte dos Santos, C.N.D., Post, P.R., Carvalho, R., Ferreira, I.I., Rice, C.M. and Galler, R. Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. Virus Research 1995, 35, 35.
11. 11 Rice, C.M., Lenches, E., Eddy, S.R., Shin, S.J., Sheets, R.L. and Strauss, J.H. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 1985, 229, 726.
12. 12 Schoub, B.D., Dommann, C.J., Johnson, S., Downie, C. and Patel, P.L. Encephalitis in a 13-year old boy following 17D YF vaccine. Journal of Infection 1990, 21, 105.
13. 13 Merlo, C., Steffen, R., Landis, T., Tsai, T. and Karabatsos, N. Possible association of encephalitis and a 17D YF vaccination in a 29-year old traveller. Vaccine 1993, 11, 691.
14. 14 Despres, P., Cahour, A. and Dupuy, A. et al. High genetic stability of the coding region for the structural proteins of yellow fever virus strain 17D. Journal of General Virology 1987, 68, 2245.